arrow_back Back to App

Guaranteed Federal Funding for Pediatric Cancer Research.

This law ensures that a specific portion of federal cancer research funds is dedicated solely to pediatric cancer studies. Starting in 2026, the funding percentage for pediatric research must match the proportion of individuals under 18 in the total US population. This change aims to accelerate the discovery of new treatments and improve outcomes for children battling cancer.
Key points
Establishes a mandatory minimum funding level for childhood cancer research, tied directly to the percentage of minors in the US population.
Reallocates federal medical research funds to prioritize pediatric cancer, effective from fiscal year 2026.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6054
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-11-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fairness to Kids with Cancer Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_6054.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-11-17.

What are the main provisions?

Key points include:

  • Establishes a mandatory minimum funding level for childhood cancer research, tied directly to the percentage of minors in the US population.
  • Reallocates federal medical research funds to prioritize pediatric cancer, effective from fiscal year 2026.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Public Investments